The Bioequivalence Of Two Different Lurasidone Formulations In Patients
NCT01082250
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Lurasidone HCl
Sponsor
Sumitomo Pharma America, Inc.